Anzeige
Mehr »
Donnerstag, 31.07.2025 - Börsentäglich über 12.000 News
Geheime Millionen-Käufe in Bitcoin & Altcoins - ohne Wallet, ohne Risiko? Jetzt wird's spannend
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JNLV | ISIN: CA46604F1099 | Ticker-Symbol: 1R3
Tradegate
30.07.25 | 14:47
0,168 Euro
+0,60 % +0,001
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IZOTROPIC CORPORATION Chart 1 Jahr
5-Tage-Chart
IZOTROPIC CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,1530,17930.07.
0,0000,00030.07.

Aktuelle News zur IZOTROPIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiIzotropic Corp: Izotropic compares IzoView with breast imaging tech1
16.07.Izotropic Corp: Izotropic to raise IzoView breast CT imaging awareness9
IZOTROPIC Aktie jetzt für 0€ handeln
15.07.Izotropic Corporation: Izotropic Prepares New Platforms to Educate and Engage159- Strategic awareness initiatives underway ahead of IzoView commercialization -- Company podcast and breasct.com website in development to expand engagement -- Market-facing activities aligned with...
► Artikel lesen
13.06.Izotropic Corp: Izotropic hires Evolux Capital for marketing services12
13.06.Izotropic Corporation: Izotropic Provides Marketing Update294Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - June 13, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
10.06.Izotropic Corp: Izotropic, California university regents revise licence11
10.06.Izotropic Corporation: Izotropic Revises License Agreement with The Regents of the University of California205- License agreement enables U.S. FDA approval or foreign equivalent (CE mark) -- Amendment aligns with Company's timelines for IzoView product launch -- Agreement amendment fees of USD $85K payable...
► Artikel lesen
20.05.EQS-News: Izotropic Corporation: FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update656EQS-News: Izotropic Corporation / Schlagwort(e): Miscellaneous FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update 20.05.2025 / 21:48 CET/CEST Für...
► Artikel lesen
17.05.Izotropic Corp: Izotropic in financing meetings for U.S. clinical study6
17.05.Izotropic Corporation: Izotropic's U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update1.088- Regulatory alignment with FDA confirmed, clearing path to pivotal U.S. clinical trial -- 150-page strategic business plan and advanced financial models completed -- Investor outreach launched to...
► Artikel lesen
03.04.Izotropic Corp: Izotropic hires international communications consultant5
02.04.Izotropic Corporation: Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender597Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 2, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
25.03.Izotropic Corp: Izotropic completes presubmission meeting with FDA4
25.03.Izotropic Corporation: Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication240- FDA meeting facilitated positive collaborative exchange -- Key topics included the clinical study protocol synopsis, the benefits versus risks of contrast-enhancement, and the management of breast...
► Artikel lesen
10.03.Izotropic Corporation: Izotropic to Present at Investor Conference March 13th305- CEO to discuss IzoView's competitive advantage, expansion strategy, and potential revenue models -- Event includes live Q and A, attendance is complimentary -- Individual and institutional investors...
► Artikel lesen
19.02.Izotropic Corp: Izotropic to meet with U.S. FDA on March 2019
19.02.Izotropic Corporation: FDA Sets Meeting Date with Izotropic265Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 19, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
14.02.Izotropic Corp: Izotropic closes $455,000 private placement2
14.02.Izotropic Corporation: Izotropic Closes Non-Brokered Private Placement320Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 14, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
07.02.Izotropic Corp: Izotropic arranges $360,000 private placement2
Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1